A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia
Key facts
- Who runs it
- Zhonghao Fang
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 2,700 people, planned
- Started
- 1 May 2026
- Expected to end
- 28 May 2028
- Type of study
- Observational, 3 groups
- Record updated
- 5 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criterionHide the full registry criteria
Other criteria
- Inclusion and Exclusion Criteria for Pneumonia Patients 1.1 Inclusion Criteria 1) Age ≥ 18 years old; 2) Meeting the diagnostic criteria for pneumonia (acute onset + new infiltrates on imaging); 3) Time from onset to admission ≤ 72 hours; 4) Signed written informed consent. 1.1.1 Inclusion Criteria for Severe Pneumonia Patients A diagnosis of "severe pneumonia" can be made if one of the main criteria or ≥ 3 of the secondary criteria are met; Main Criteria:; ① Requires mechanical ventilation with tracheal intubation; ② Requires vasopressor drugs after aggressive fluid resuscitation for septic shock; Secondary Criteria:; Respiratory rate ≥ 30 breaths/min; PaO₂/FiO₂ ≤ 250 mm Hg; Multiple lobe infiltrates; Confusion and/or disorientation; ⑤ Blood urea nitrogen ≥ 20 mg/dL; ⑥ Leukopenia (WBC < 4×10⁹/L); ⑦ Thrombocytopenia (PLT < 100×10⁹/L); ⑧ Decreased body temperature (central body temperature < 36 ℃); ⑨ Hypotension requiring fluid resuscitation 1.2 Exclusion Criteria; End-stage diseases (such as expected survival < 48 hours); Long-term immunosuppressive therapy (prednisone > 20mg/d for more than 3 weeks, or neutropenia after chemotherapy); Pregnant or lactating women. 2. Inclusion and Exclusion Criteria for Patients with Suspected Infection but Negative Pathogen Testing 2.1 Inclusion Criteria; <!-- -->; Age ≥ 18 years old; Having infection-related symptoms or signs (such as fever, cough, sputum production, elevated white blood cells, etc.), clinically suspected of pneumonia; All pathogen tests are negative within 3 days after admission; Time from onset to admission ≤ 72 hours; Signed written informed consent. 2.2 Exclusion Criteria; <!-- -->; End-stage diseases (such as expected survival < 48 hours); Long-term immunosuppressive therapy; Pregnant or lactating women
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Pneumonia
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective, multicenter observational cohort study involving approximately 2,700 patients, designed to delineate the natural history of pneumonia by tracking the complete clinical course and dynamic multi-omics evolution from the acute phase to recovery; the study aims to quantify severe conversion rates and mortality by comparing baseline characteristics, pathogen distribution, and immune response trajectories between severe and non-severe groups, ultimately revealing the underlying molecular mechanisms of disease progression and optimizing clinical risk stratification strategies.
The 3 groups in the trial
- pneumonia
- Severe pneumonia
- Non-infection control group
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07567911, who can take part
- Record updated
- 5 May 2026